Literature DB >> 23608840

Primary T-cell lymphoma of liver.

S Mishra1, A Shukla, A K Tripathi, A Kumar.   

Abstract

Primary hepatic lymphoma (PHL) is rare and represents approximately 0.016% of all cases of non-Hodgkin's lymphoma (NHL). The majority of these are B-cell NHL of diffuse large B-cell type. Primary T-cell lymphoma constitutes approximately 5-10% of all PHLs arising in the liver, 90% being B-cell type. Peripheral T-cell lymphoma, γδ hepatosplenic T-cell lymphoma and αβ hepatosplenic T-cell lymphoma are the common T-cell lymphomas involving hepatic parenchyma. We encountered a case presenting with gross hepatomegaly extending beyond umbilicus, mild ascites, pedal oedema, icterus and dyspnoea. Haemogram showed moderate anaemia with counts. Bone marrow aspiration showed erythroid hyperplasia with dimorphic anaemia. There was no evidence of atypical lymphoid cells in peripheral blood of bone marrow. We present a rare case of primary T-cell lymphoma presenting as primary liver involvement without splenomegaly, lymphadenopathy, bone marrow or peripheral blood involvement.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23608840      PMCID: PMC3644887          DOI: 10.1136/bcr-2012-008467

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  Primary focal T-cell lymphoma of the liver: a case report and review of the literature.

Authors:  Razvan Cerban; Liana Gheorghe; Gabriel Becheanu; Valentin Serban; Cristian Gheorghe
Journal:  J Gastrointestin Liver Dis       Date:  2012-06       Impact factor: 2.008

Review 2.  Primary hepatic peripheral T-cell lymphoma treated with corticosteroid.

Authors:  Kazuho Miyashita; Naoto Tomita; Hisashi Oshiro; Chihiro Matsumoto; Yuki Nakajima; Satomi Ito; Kenji Matsumoto; Hiroyuki Fujita; Yoshiaki Ishigatsubo
Journal:  Intern Med       Date:  2011-03-15       Impact factor: 1.271

Review 3.  Primary non-Hodgkin's lymphoma of the liver.

Authors:  Vanita Noronha; Nelofar Q Shafi; J Antonio Obando; Shivaani Kummar
Journal:  Crit Rev Oncol Hematol       Date:  2005-03       Impact factor: 6.312

4.  Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma.

Authors:  F Cabanillas; J Rodriguez-Diaz Pavón; F B Hagemeister; P McLaughlin; M A Rodriguez; J E Romaguera; K Dong; T Moon
Journal:  Ann Oncol       Date:  1998-05       Impact factor: 32.976

5.  Aggressive primary hepatic lymphoma in Chinese patients. Presentation, pathologic features, and outcome.

Authors:  K I Lei; J H Chow; P J Johnson
Journal:  Cancer       Date:  1995-10-15       Impact factor: 6.860

Review 6.  Non-Hodgkin's lymphoma involving the liver: clinical and therapeutic considerations.

Authors:  J Stuart Salmon; Mary Ann Thompson; Ronald C Arildsen; John P Greer
Journal:  Clin Lymphoma Myeloma       Date:  2006-01

7.  Peripheral T-cell lymphoma arising in the liver.

Authors:  Mirela Stancu; Dan Jones; Francisco Vega; L Jeffrey Medeiros
Journal:  Am J Clin Pathol       Date:  2002-10       Impact factor: 2.493

8.  Primary lymphoma of the liver in the acquired immunodeficiency syndrome.

Authors:  D Caccamo; N K Pervez; A Marchevsky
Journal:  Arch Pathol Lab Med       Date:  1986-06       Impact factor: 5.534

Review 9.  Hepatitis C virus infection and B-cell non-Hodgkin's lymphomas: more than a simple association.

Authors:  Pellegrino Musto
Journal:  Clin Lymphoma       Date:  2002-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.